» Articles » PMID: 35804833

GraphChrom: A Novel Graph-Based Framework for Cancer Classification Using Chromosomal Rearrangement Endpoints

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Jul 9
PMID 35804833
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosomal rearrangements are generally a consequence of improperly repaired double-strand breaks in DNA. These genomic aberrations can be a driver of cancers. Here, we investigated the use of chromosomal rearrangements for classification of cancer tumors and the effect of inter- and intrachromosomal rearrangements in cancer classification. We used data from the Catalogue of Somatic Mutations in Cancer (COSMIC) for breast, pancreatic, and prostate cancers, for which the COSMIC dataset reports the highest number of chromosomal aberrations. We developed a framework known as GraphChrom for cancer classification. GraphChrom was developed using a graph neural network which models the complex structure of chromosomal aberrations (CA) and provides local connectivity between the aberrations. The proposed framework illustrates three important contributions to the field of cancers. Firstly, it successfully classifies cancer types and subtypes. Secondly, it evolved into a novel data extraction technique which can be used to extract more informative graphs (informative aberrations associated with a sample); and thirdly, it predicts that interCAs (rearrangements between two or more chromosomes) are more effective in cancer prediction than intraCAs (rearrangements within the same chromosome), although intraCAs are three times more likely to occur than intraCAs.

Citing Articles

The New Era of Cancer Cytogenetics and Cytogenomics.

Ye J, Heng H Methods Mol Biol. 2024; 2825:3-37.

PMID: 38913301 DOI: 10.1007/978-1-0716-3946-7_1.


Multi-Omics Integration for Liver Cancer Using Regression Analysis.

Raj A, Petreaca R, Mirzaei G Curr Issues Mol Biol. 2024; 46(4):3551-3562.

PMID: 38666952 PMC: 11049490. DOI: 10.3390/cimb46040222.


Constructing gene similarity networks using co-occurrence probabilities.

Mirzaei G BMC Genomics. 2023; 24(1):697.

PMID: 37990157 PMC: 10662556. DOI: 10.1186/s12864-023-09780-w.


Challenges and Opportunities for Clinical Cytogenetics in the 21st Century.

Heng E, Thanedar S, Heng H Genes (Basel). 2023; 14(2).

PMID: 36833419 PMC: 9956237. DOI: 10.3390/genes14020493.


BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.

Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E Cancers (Basel). 2022; 14(16).

PMID: 36010882 PMC: 9405840. DOI: 10.3390/cancers14163888.

References
1.
Li Y, Roberts N, Wala J, Shapira O, Schumacher S, Kumar K . Patterns of somatic structural variation in human cancer genomes. Nature. 2020; 578(7793):112-121. PMC: 7025897. DOI: 10.1038/s41586-019-1913-9. View

2.
Gao L, Ye M, Lu X, Huang D . Hybrid Method Based on Information Gain and Support Vector Machine for Gene Selection in Cancer Classification. Genomics Proteomics Bioinformatics. 2017; 15(6):389-395. PMC: 5828665. DOI: 10.1016/j.gpb.2017.08.002. View

3.
Wang Y, Wu N, Liu J, Wu Z, Dong D . FusionCancer: a database of cancer fusion genes derived from RNA-seq data. Diagn Pathol. 2015; 10:131. PMC: 4517624. DOI: 10.1186/s13000-015-0310-4. View

4.
Latysheva N, Babu M . Discovering and understanding oncogenic gene fusions through data intensive computational approaches. Nucleic Acids Res. 2016; 44(10):4487-503. PMC: 4889949. DOI: 10.1093/nar/gkw282. View

5.
Prado-Vazquez G, Gamez-Pozo A, Trilla-Fuertes L, Arevalillo J, Zapater-Moros A, Ferrer-Gomez M . A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses. Sci Rep. 2019; 9(1):1538. PMC: 6367406. DOI: 10.1038/s41598-018-38364-y. View